Skip to main content
. 2018 Sep 21;11:6139–6145. doi: 10.2147/OTT.S168057

Table 1.

Patient characteristics in the study

Items
Age, mean±SD 57.8±13.6
Histological grade, n (%)
 I 14 (11.3)
 II 82 (66.1)
 III 28 (22.6)
ER expression, n (%)
 Negative 33 (26.2)
 Positive 93 (73.8)
PR expression, n (%)
 Negative 44 (34.9)
 Positive 82 (65.1)
HER2 amplification, n (%)
 Negative 64 (74.4)
 Positive 22 (25.6)
Molecular subtype, n (%)
 Luminal A 65 (54.2)
 Luminal B 34 (28.3)
 HER2 overexpression 10 (8.3)
 TNBC 11 (9.2)

Abbreviation: TNBC, triple-negative breast cancer.